Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06696014 · ClinicalTrials.gov registry record
Mirikizumab Real World Protocol
A clinical trial of Ulcerative Colitis, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- 100
- Enrollment target
- 9
- Study locations
NCT06696014 is a study of Ulcerative Colitis that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 100 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (95% lower). The trial reports 9 study locations across 9 states.
The verdict
NCT06696014, a study of Ulcerative Colitis, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 9
- Study locations
Study Summary
The goal of this observational study is to learn about how effective mirikizumab (Omvoh) is when treating patients with ulcerative colitis (UC) Does mirikizumab (Omvoh) lead to a reduction in symptoms at intervals throughout one year? Participants being prescribed mirikizumab (Omvoh) as part of their regular medical care for UC will answer online survey questions about their bowel habits for 1 year.
Conditions Studied
Study Locations (9)
Colorado
- South Denver Gastroenterology - Denver
Florida
- AdventHealth - Orlando
Iowa
- University of Iowa Health Care - Iowa City
Kentucky
- University of Louisville, Clinical Trials Unit - Louisville
New York
- University Of Rochester Medical Center - Rochester
North Carolina
- University of North Carolina - Chapel Hill
South Carolina
- Medical University of South Carolina (MUSC) - Charleston
Texas
- Southern Star Research Institute, LLC - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06696014
The ClinicalTrials.gov registry entry for NCT06696014 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (95% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 0 interventions.
NCT06696014 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Colorado, Florida, Iowa.
Frequently Asked Questions
What is clinical trial NCT06696014 about?
NCT06696014 is a clinical study titled "Mirikizumab Real World Protocol". The goal of this observational study is to learn about how effective mirikizumab (Omvoh) is when treating patients with ulcerative colitis (UC) Does mirikizumab (Omvoh) lead to a reduction in symptoms at intervals throughout one year? Participants being prescribed mirikizumab (Omvoh) as part of th...
What is the current status of trial NCT06696014?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-05-08. Estimated completion is 2030-01.
What conditions does trial NCT06696014 study?
This clinical trial studies the following conditions: Ulcerative Colitis.
Who is sponsoring clinical trial NCT06696014?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06696014 being conducted?
This trial has 9 study locations across Colorado, Florida, Iowa, Kentucky, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RECRUITING · Phase 2
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.